The 2012 BSR and BHPR guideline for the treatment of psoriatic arthritis with biologics

Laura C Coates; William Tillett; David Chandler; Philip S Helliwell; Eleanor Korendowych; Stuart Kyle; Iain B McInnes; Susan Oliver; Anthony Ormerod; Catherine Smith; Deborah Symmons; Nicola Waldron; Neil J McHugh; BSR Clinical Affairs Committee & Standards, Audit and Guidelines Working Group and the BHPR

doi:10.1093/rheumatology/ket187

The 2012 BSR and BHPR guideline for the treatment of psoriatic arthritis with biologics

Laura C Coates, William Tillett, David Chandler, Philip S Helliwell, Eleanor Korendowych, Stuart Kyle, Iain B McInnes, Susan Oliver, Anthony Ormerod, Catherine Smith, Deborah Symmons, Nicola Waldron, Neil J McHugh, BSR Clinical Affairs Committee & Standards, Audit and Guidelines Working Group and the BHPR

Royal National Hospital for Rheumatic Diseases

Research output: Contribution to journal › Article › peer-review

73 Citations (Scopus)

Original language	English
Pages (from-to)	1754-1757
Number of pages	4
Journal	Rheumatology
Volume	52
Issue number	10
Early online date	25 Jul 2013
DOIs	https://doi.org/10.1093/rheumatology/ket187
Publication status	Published - Oct 2013

Keywords

algorithms
antirheumatic agents
arthritis, psoriatic
biological products
humans
treatment failure
tumor necrosis factor-alpha
biologics
treatment
management
guidelines
recommendations
anti-TNF therapies
psoriasis
enthesitis
dactylitis

Access to Document

10.1093/rheumatology/ket187

Cite this

Coates, L. C., Tillett, W., Chandler, D., Helliwell, P. S., Korendowych, E., Kyle, S., McInnes, I. B., Oliver, S., Ormerod, A., Smith, C., Symmons, D., Waldron, N., McHugh, N. J., & BSR Clinical Affairs Committee & Standards, Audit and Guidelines Working Group and the BHPR (2013). The 2012 BSR and BHPR guideline for the treatment of psoriatic arthritis with biologics. Rheumatology, 52(10), 1754-1757. https://doi.org/10.1093/rheumatology/ket187

Coates, LC, Tillett, W, Chandler, D, Helliwell, PS, Korendowych, E, Kyle, S, McInnes, IB, Oliver, S, Ormerod, A, Smith, C, Symmons, D, Waldron, N, McHugh, NJ & BSR Clinical Affairs Committee & Standards, Audit and Guidelines Working Group and the BHPR 2013, 'The 2012 BSR and BHPR guideline for the treatment of psoriatic arthritis with biologics', Rheumatology, vol. 52, no. 10, pp. 1754-1757. https://doi.org/10.1093/rheumatology/ket187

@article{2b1b4386085e451baea76764bb42da0c,

title = "The 2012 BSR and BHPR guideline for the treatment of psoriatic arthritis with biologics",

keywords = "algorithms, antirheumatic agents, arthritis, psoriatic, biological products, humans, treatment failure, tumor necrosis factor-alpha, biologics, treatment, management, guidelines, recommendations, anti-TNF therapies, psoriasis, enthesitis, dactylitis",

author = "Coates, {Laura C} and William Tillett and David Chandler and Helliwell, {Philip S} and Eleanor Korendowych and Stuart Kyle and McInnes, {Iain B} and Susan Oliver and Anthony Ormerod and Catherine Smith and Deborah Symmons and Nicola Waldron and McHugh, {Neil J} and {BSR Clinical Affairs Committee & Standards, Audit and Guidelines Working Group and the BHPR}",

year = "2013",

month = oct,

doi = "10.1093/rheumatology/ket187",

language = "English",

volume = "52",

pages = "1754--1757",

journal = "Rheumatology",

issn = "1462-0324",

publisher = "OXFORD UNIV PRESS INC",

number = "10",

}

TY - JOUR

T1 - The 2012 BSR and BHPR guideline for the treatment of psoriatic arthritis with biologics

AU - Coates, Laura C

AU - Tillett, William

AU - Chandler, David

AU - Helliwell, Philip S

AU - Korendowych, Eleanor

AU - Kyle, Stuart

AU - McInnes, Iain B

AU - Oliver, Susan

AU - Ormerod, Anthony

AU - Smith, Catherine

AU - Symmons, Deborah

AU - Waldron, Nicola

AU - McHugh, Neil J

AU - BSR Clinical Affairs Committee & Standards, Audit and Guidelines Working Group and the BHPR

PY - 2013/10

Y1 - 2013/10

KW - algorithms

KW - antirheumatic agents

KW - arthritis, psoriatic

KW - biological products

KW - humans

KW - treatment failure

KW - tumor necrosis factor-alpha

KW - biologics

KW - treatment

KW - management

KW - guidelines

KW - recommendations

KW - anti-TNF therapies

KW - psoriasis

KW - enthesitis

KW - dactylitis

U2 - 10.1093/rheumatology/ket187

DO - 10.1093/rheumatology/ket187

M3 - Article

C2 - 23887065

SN - 1462-0324

VL - 52

SP - 1754

EP - 1757

JO - Rheumatology

JF - Rheumatology

IS - 10

ER -